Autopsy report · NCT01678144
Study on Safety and Performance of Medtentia Mitral Valve Repair System in Surgical Repair of Mitral Regurgitation
Cause of deathFunding or business
“Strategic decision by Sponsor”
Life of this trial
- Registered 1 year 2 months after it had already started.
- Ran for about 4 years 10 months before it stopped.
- 12 participants enrolled.
- Results were posted on the registry 3 years 4 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Medtentia International Ltd Oy
- Sponsor type
- Industry
- Conditions
- Mitral Regurgitation; Mitral Insufficiency
- Interventions
- Mitral valve repair using the Medtentia Annuloplasty Ring (MAR)
- Participants
- 12
- Sites
- 1
- Countries
- Finland
Trials that died the same way
- Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness
“Strategic decision of Sponsor” - Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19
“Sponsor's strategic decision” - Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant
“Strategic sponsor decision” - Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis
“Sponsor decision due to strategic considerations” - A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
“Sponsor's strategic business decision”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.